Fiorentino Grasso

Fiorentino Grasso

Auto-generated profile, based on publicly available information

Fiorentino Grasso

Section of Neonatology, Department of Translational Medical Sciences, Federico II University, Naples, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
FGFiorentino Grasso
Fiorentino Grasso
ACAntonella Capasso
Antonella Capasso
DPDaniela Pacella
Daniela Pacella
FBFrancesco Borgia
Francesco Borgia
SSSerena Salomè
Serena Salomè
FRFrancesco Raimondi
Francesco Raimondi

12 September 2018 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
FGFiorentino Grasso
Fiorentino Grasso
ECEmilia Cirillo
Emilia Cirillo
GQGiuseppe Quaremba
Giuseppe Quaremba
VGVincenzo Graziano
Vincenzo Graziano
VGVera Gallo
Vera Gallo
SMSergio Motta
Sergio Motta

1 July 2025 in European Journal of Pediatrics
Verified
Journal Article
Closed access
FGFiorentino Grasso
Fiorentino Grasso
FMFiorella Migliaro
Fiorella Migliaro
CVClaudio Veropalumbo
Claudio Veropalumbo
SSSerena Salomè
Serena Salomè
ICIuri Corsini
Iuri Corsini
LCLetizia Capasso
Letizia Capasso

20 December 2025 in Critical Care
Verified
Journal Article
Open access
PDF file
FGFiorentino Grasso
Fiorentino Grasso
ACAntonella Capasso
Antonella Capasso
PDPasquale Dolce
Pasquale Dolce
GAGaetano Ausanio
Gaetano Ausanio
IBItalo Bernardo
Italo Bernardo
FRFrancesco Raimondi
Francesco Raimondi
Incorrect neonatal peripherally inserted central catheter (n-PICC) tip positioning and secondary migration lead to serious complications. Identifying an ac

2 July 2024 in Trials
Verified
Journal Article
Open access
GVGiovanni Vento
Giovanni Vento
APAngela Paladini
Angela Paladini
CAC. Aurilia
C. Aurilia
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
VCV. P. Carnielli
V. P. Carnielli
EZE. Zannin
E. Zannin
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD); however, the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less-invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study, 382 infants born at 24+0–27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. The secondary outcomes are BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular hemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes; and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include center and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0–27+6 weeks’ gestation affected by RDS and failing nCPAP or NIPPV during the first 24 h of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks’ postmenstrual age of life. Trial registration: ClinicalTrials.gov NCT05711966. Registered on February 3, 2023.

23 May 2026 in Neonatology
Verified
Journal Article
Closed access
PDF file
ACAntonella Capasso
Antonella Capasso
FGFiorentino Grasso
Fiorentino Grasso
MMMario Meliande
Mario Meliande
SSSerena Salomè
Serena Salomè
LCLetizia Capasso
Letizia Capasso
FRFrancesco Raimondi
Francesco Raimondi
Introduction: Peripherally inserted central catheters (n-PICCs) are standard in neonatal intensive care but carry high complication rates. Ultrasound-guided non-tunneled centrally inserted central catheters (nT-CICCs) offer a potential alternative. This study compared outcomes of nT-CICCs versus n-PICCs in extremely low birth weight (ELBW) neonates. Methods: Single-center, comparative cohort study (April 2022–October 2025) enrolling neonates <1000g requiring central venous access. A retrospective cohort receiving n-PICCs was compared with a prospective cohort receiving nT-CICCs. The primary outcome was Central Line-Associated Bloodstream Infection (CLABSI) density rate on successfully placed catheters. Secondary outcomes included procedural success, mechanical complications, and risk factors for CLABSI. Results: We analyzed 103 catheter insertions (50 nT-CICCs, 53 n-PICCs). Procedural success was 100% for nT-CICCs and 94% for n-PICCs (3 immediate failures excluded from follow-up). Among 100 indwelling catheters, nT-CICCs showed significantly lower CLABSI rates (1.83 vs 11.09 per 1000 catheter-days; P = .038). Overall complications affected 4% of the nT-CICC group versus 64% of the n-PICC group (P < .001). nT-CICCs enabled therapy completion in 66% of cases compared with 12% for n-PICCs. Catheter type was the sole independent predictor of CLABSI (adjusted HR 7.1, 95% CI 1.01-49.74; P = .048). Conclusions: Ultrasound-guided nT-CICCs are associated with significantly lower rates of infectious and mechanical complications compared with n-PICCs in ELBW neonates. This approach provides a safer and more durable option for central venous access in this vulnerable population.